H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.
Clin Cancer Res. 2010 Dec 15;16(24):5987-96. doi: 10.1158/1078-0432.CCR-10-1216.
The Patient Protection and Affordable Care Act of 2010 will have a profound influence on health care in the United States, including how we conduct cancer research and cancer care delivery. For this reason, oncologists and researchers must be intimately involved in the implementation and interpretation of this important legislation. A major goal of the Act is to improve access to affordable, quality health care. An important element in achieving this goal will be to learn from patients' experiences and build the foundation for evidence-based personalized medicine. This will require a partnership among researchers, clinicians, policy makers and regulators, and patients to design an integrated information network system that will be the basis for providing the right treatment for the right patient in the right place at the right time. In this review, we will discuss the salient points of the Act that specifically affect cancer research and care, as well as highlight opportunities for oncologists and researchers to play a primary role in developing a health care system that includes personalized medicine approaches that will in turn enhance the likelihood of achieving the goals and objectives of the health care reform act.
2010 年的《患者保护与平价医疗法案》将对美国的医疗保健产生深远影响,包括我们进行癌症研究和提供癌症护理的方式。出于这个原因,肿瘤学家和研究人员必须密切参与这项重要立法的实施和解释。该法案的主要目标之一是改善获得负担得起的、高质量医疗保健的机会。实现这一目标的一个重要因素将是从患者的经验中学习,并为循证个性化医学奠定基础。这将需要研究人员、临床医生、政策制定者和监管者以及患者之间的合作,设计一个集成的信息网络系统,作为在正确的时间、在正确的地点为正确的患者提供正确治疗的基础。在这篇综述中,我们将讨论该法案中特别影响癌症研究和护理的要点,并强调肿瘤学家和研究人员在制定医疗保健系统方面发挥主要作用的机会,该系统将包括个性化医学方法,从而提高实现医疗改革法案的目标和目的的可能性。